Christopher J. Wilson, et al. Gene Editing Specificity Assessment for EDIT-101, an LCA10 Therapeutic Candidate. Presented at the American Society of Gene & Cell Therapy (ASGCT) 21st Annual Meeting, May 16 – 19.

May

2

Editas Medicine Announces First Quarter 2024 Results Conference Call and Upcoming Investor Events

May

1

Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration

Apr

22

Editas Medicine to Present Pre-clinical Data Demonstrating Progression of in vivo Medicines Pipeline at the American Society of Gene and Cell Therapy Annual Meeting